Results 81 to 90 of about 242,018 (254)

Audit Risk Disclosures, Targeted Inspections, and Audit Quality Information obligatoire sur les risques d'audit, inspections ciblées et qualité des audits

open access: yesContemporary Accounting Research, EarlyView.
ABSTRACT This article studies how the mandatory disclosure of audit risk and targeted regulatory inspections influence audit quality. We develop a model in which the auditor tests a firm's internal control over financial reporting before auditing the financial report and must issue an opinion on both.
Kyungha Lee, Rahul Menon
wiley   +1 more source

PB2673: EXPERIENCES AND VIEWS OF LEUKEMIA CARERS: A GLOBAL SURVEY

open access: yesHemaSphere, 2023
Samantha Nier   +11 more
doaj   +1 more source

The expression and signalling patterns of CD180 toll like receptor in Chronic Lymphocytic Leukaemia (CLL) [PDF]

open access: yes, 2019
Chronic lymphocytic leukaemia (CLL) is characterised by a progressive accumulation of mature CD5+CD20+CD23+ lymphocytes. Despite the remarkable progress in our understanding of the immunobiology of CLL, the aetiology of the disease remains unknown.
Sayed, U., Sayed, U.
core  

How Well Are Dental Students Equipped to Handle Traumatic Dental Injuries in Children?

open access: yesAustralian Endodontic Journal, EarlyView.
ABSTRACT To evaluate dental students' knowledge and confidence in managing dental trauma (TDI). An observational questionnaire‐based study involving fourth‐year BDSc (Hons) students from 2022 and 2023 at UQ, following their Traumatic Dental Injury module.
Sobia Zafar   +4 more
wiley   +1 more source

PB1936: IDENTIFYING INEQUITIES IN SUPPORT - GLOBAL SURVEY OF PATIENT ORGANISATIONS DELIVERING SUPPORT SERVICES FOR CLL PATIENTS

open access: yesHemaSphere, 2023
Deborah Baker   +17 more
doaj   +1 more source

An unusual case of HHV-8 negative, idiopathic, multicentric Castleman disease following chronic lymphocytic leukaemia

open access: yesEuropean Journal of Case Reports in Internal Medicine
Background: Castleman disease is a rare condition characterised by polytypic lymphocytes proliferation and lymphadenopathy generally with a benign course.
Pierre-Yves Sansen   +6 more
doaj   +1 more source

The regulatory capacity of B cells directs the aggressiveness of CLL

open access: yesOncoImmunology, 2019
Chronic lymphocytic leukemia (CLL) is associated with abnormal T-cell responses responsible for defective anti-tumor activities. Intriguingly, CLL B cells share phenotypical characteristics with regulatory B (Breg) cells suggesting that they might ...
Audrey Mohr   +12 more
doaj   +1 more source

Evidence for somatic selection of natural autoantibodies. [PDF]

open access: yes, 1992
Natural autoantibodies are primarily immunoglobulin M (IgM) antibodies that bind to a variety of self-antigens, including self-IgG. Accounting for a large proportion of the early B cell repertoire, such polyspecific autoantibodies are speculated to ...
Carson, DA   +3 more
core  

Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy

open access: yesAndrology, EarlyView.
ABSTRACT Background Androgen receptors are highly expressed in upper body muscles, but changes in maximal muscle strength and power in major upper body muscles have not been investigated during gender‐affirming hormone therapy (GAHT). Objective To assess prospective changes in maximal muscle strength and muscle power from before and after 1 year of ...
Mathilde Kamp Nørlund   +12 more
wiley   +1 more source

Atypical case of B-cell Chronic Lymphocytic Leukemia presenting with extreme hyperleukocytosis / Hiperleucocitoză extremă într-un caz atipic de leucemie limfatică cronică cu celulă B

open access: yesRomanian Journal of Laboratory Medicine, 2014
În literatura de specialitate sunt prezentate foarte puține cazuri de leucemie limfocitară cronică (LLC), care debutează cu hiperleucocitoză extremă. Descriem cazul unei femei în vârstă de 66 ani, care se prezintă cu hiperleucocitoză extremă de 774.2 x ...
Bacârea Anca   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy